Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Interleukin-12 Therapy Reduces the Number of Immune Cells and Pathology in Lungs of Mice Infected with Mycobacterium tuberculosis
Dawn Nolt
, Jo Anne L. Flynn
Research output
:
Contribution to journal
›
Article
›
peer-review
30
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Interleukin-12 Therapy Reduces the Number of Immune Cells and Pathology in Lungs of Mice Infected with Mycobacterium tuberculosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Agriculture & Biology
interleukin-12
100%
Mycobacterium tuberculosis
88%
lungs
58%
therapeutics
57%
mice
42%
cells
23%
disease models
12%
natural killer cells
11%
granuloma
11%
immunosuppression
10%
interferon-gamma
10%
tuberculosis
10%
infection
9%
dosage
9%
T-lymphocytes
8%
disease control
8%
immune response
7%
lymphocytes
7%
Medicine & Life Sciences
Interleukin-12
76%
Mycobacterium tuberculosis
72%
Cell Count
55%
Pathology
46%
Lung
39%
Tuberculosis
22%
Therapeutics
12%
Bacterial Load
10%
Granuloma
9%
Infection Control
9%
Natural Killer Cells
8%
Immunosuppression
8%
Interferon-gamma
8%
Lymphocytes
6%
T-Lymphocytes
5%
Survival
5%